Viewing Study NCT00230334


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2025-12-27 @ 11:24 PM
Study NCT ID: NCT00230334
Status: TERMINATED
Last Update Posted: 2021-05-10
First Post: 2005-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Gleevec Idiopathic Hypereosinophilic Syndrome
Sponsor: Steven E. Coutre
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module